SISajjad Iraji

Sajjad Iraji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sajjad Iraji has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Functional Magnetic Resonance Spectroscopy of Lactate in Alzheimer Disease: A Comprehensive Review of Alzheimer Disease Pathology and the Role of Lactate

    by Kiarash Bsc Shirbandi, Reza Rikhtegar, Mohammad Khalafi, Mohammad Mirza Aghazadeh Attari, Farzaneh Rahmani, Pouya Bsc Javanmardi, Sajjad Msc Iraji, Zahra Babaei Aghdam, Amir Mohammad Msc Rezaei Rashnoudi

    Functional 1H magnetic resonance spectroscopy (fMRS) is a derivative of dynamic MRS imaging. This modality links physiologic metabolic responses with available activity and measures absolute or relative concentrations of various metabolites. According to clinical evidence, the mitochondrial glycolysis pathway is disrupted in many nervous system disorders, especially Alzheimer disease, resulting in the activation of anaerobic glycolysis and an increased rate of lactate production. Our study evaluates fMRS with J-editing as a cutting-edge technique to detect lactate in Alzheimer disease. In this modality, functional activation is highlighted by signal subtractions of lipids and macromolecules, which yields a much higher signal-to-noise ratio and enables better detection of trace levels of lactate compared with other modalities. However, until now, clinical evidence is not conclusive regarding the widespread use of this diagnostic method. The complex machinery of cellular and noncellular modulators in lactate metabolism has obscured the potential roles fMRS imaging can have in dementia diagnosis. Recent developments in MRI imaging such as the advent of 7 Tesla machines and new image reconstruction methods, coupled with a renewed interest in the molecular and cellular basis of Alzheimer disease, have reinvigorated the drive to establish new clinical options for the early detection of Alzheimer disease. Based on the latter, lactate has the potential to be investigated as a novel diagnostic and prognostic marker for Alzheimer disease.


  • Open Access

    CTtrack: A CNN+Transformer-based framework for fiber orientation estimation & tractography

    by S.M.H. Hosseini, M. Hassanpour, S. Masoudnia, S. Iraji, S. Raminfard, M. Nazem-Zadeh


  • Open Access

    Transformer-Based Framework for Fiber Orientation Estimation & Tractography

    by Seyed-Mohammad Hossein Hosseini, Masoud Hassanpour, Saeed Masoudnia, Sajjad Iraji, Samira Raminfard, Mohammad-Reza Nazem-Zadeh

    In recent years, multiple data-driven fiber orientation distribution function (fODF) estimation algorithms and automatic tractography pipelines have been proposed to address the limitations of traditional methods. However, these approaches lack precision and generalizability. To tackle these shortcomings, we introduce a transformer-based pipeline to estimate fODFs and perform tractography. In this approach, a convolutional neural network (CNN) module is employed to project the resampled diffusion-weighted magnetic resonance imaging (DW-MRI) data to a lower dimension. Then, a transformer model estimates the fiber orientation distribution functions using the projected data within a local block around each voxel. The proposed model represents the extracted fODFs by spherical harmonics coefficients. The predicted fiber ODFs can be used for both deterministic and probabilistic tractography. Our pipeline was tested in terms of the precision and robustness in estimating fODFs and performing tractography using both simulated and real diffusion data. The Tractometer tool was employed to compare our method with the classical and data-driven tractography approaches. The qualitative and quantitative assessments illustrate the competitive performance of our framework compared to other available algorithms.


  • Open Access

    Early Detection of Radiation‐Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low‐Grade Glioma

    by Zahra Alirezaei, Alireza Amouheidari, Masoud Hassanpour, Fariba Davanian, Sajjad Iraji, Parvaneh Shokrani, Mohammad-Reza Nazem-Zadeh

    Purpose. To compare the sensitivity of MRS metabolites and MoCA and ACE‐R cognitive tests in the detection of radiation‐induced injury in low grade glioma (LGG) patients in early and early delayed postradiation stages. Methods. MRS metabolite ratios of NAA/Cr and Cho/Cr, ACE‐R and MoCA cognitive tests, and dosimetric parameters in corpus callosum were analyzed during RT and up to 6‐month post‐RT for ten LGG patients. Results. Compared to pre RT baseline, a significant decline in both NAA/Cr and Cho/Cr in the corpus callosum was seen at the 4th week of RT, 1, 3, and 6‐month post‐RT. These declines were detected at least 3 months before the detection of declines in cognitive functions by ACE‐R and MoCA tools. Moreover, NAA/Cr alterations at 4th week of RT and 1‐month post‐RT were significantly negatively correlated with the mean dose received by the corpus callosum, as well as the corpus callosum 40 Gy dose volume, i.e., the volume of the corpus callosum receiving a dose greater than 40 Gy. Conclusion. MRS‐based biomarkers may be more sensitive than the state‐of‐the‐art cognitive tests in the prediction of postradiation cognitive impairments. They would be utilized in treatment planning and dose sparing protocols, with a specific focus on the corpus callosum in the radiation therapy of LGG patients.